• Explore /
  • Poster
  • / A phase I study of oncolytic immunotherapy of metastatic neuroendocrine tumors using intralesional rose bengal disodium: Cohort 1 results.

A phase I study of oncolytic immunotherapy of metastatic neuroendocrine tumors using intralesional rose bengal disodium: Cohort 1 results.

Abstract Poster

Authors

Timothy Price

Timothy Jay Price

Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia

Timothy Jay Price , Gabby Cehic , Eric Andrew Wachter , Ian Kirkwood , Rubin Sebbon , Lisa Leopardi , Jessic Reid , Anas Alawawdeh , Susan J Neuhaus , Guy Maddern

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Neuroendocrine/Carcinoid

Clinical Trial Registration Number

NCT02693067

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4102)

DOI

10.1200/JCO.2019.37.15_suppl.4102

Abstract #

4102

Poster Bd #

207

Abstract Disclosures

Similar Posters

First Author: Timothy Jay Price

First Author: Rohini Sharma

First Author: Medhavi Gupta

First Author: Estephany Abou Jokh Casas